Novartis Raises FullYear Sales and Profit Guidance Signaling Strong Operational Momentum GEHC Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Collegium Pharmaceutical Gains Spotlight on ADHD Portfolio Strength and Q1 2026 Beat IVDA Q2 2024 Earnings EPS Beat Surprises Despite Stock Decline CCIF Q1 2026 Earnings EPS Misses Estimates Shares Rise on Portfolio Stability HURN Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction DGICB Q1 2026 Earnings EPS Misses Estimates but Stock Rises 47 LFMD Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Progress OSG Q1 2026 Earnings Staggering EPS Surprise of 2334 Highlights Strong Underlying Performance ANNX Q1 2026 Earnings EPS Surpasses Estimates by 22 as Biotech Advances Pipeline